News

The licensing deal covers a combination drug, using Zertane and another erectile dysfunction drug (PDE5 inhibitors and others), to simultaneously treat premature ejaculation and erectile dysfunction (ED). The

The trial aims to determine the tolerability, safety and pharmacokinetic profile of NKTR-181 upon repeat administration in preparation for Phase 2 clinical development in chronic pain patients. In

The trial aims to assess the safety and tolerability of intravenous ME-143 in patients with refractory solid tumors. The company expects to recruit around 24 patients with final

Naeymi-Rad will succeed John Campbell, who co-founded the firm more than 14 years ago. Campbell Alliance was acquired by inVentiv Health in February 2011 and operates as inVentiv

The new joint venture company – Jilin Pfizer Guoyuan Animal Health – will initially be responsible to develop vaccines to protect the health of swine. Jilin Guoyuan Animal

Under the contract, Maxwell will fund the Phase I and II human clinical studies of AHRO-001 in Russia. In return, AtheroNova will issue up to $4.1m in common

The recommendation is based on the results from a double-blind Rocket AF Phase 3 trial which showed that once-daily rivaroxaban had a 21% relative risk reduction in stroke

The aim of the trial is to compare the objective response rate (ORR) of carboplatin and paclitaxel with or without bavituximab in up to 86 patients with previously

Following the acquisition, Amira has become the wholly-owned subsidiary of BMS. Earlier in July 2011, BMS signed a definitive agreement to acquire Amira for $325m. The deal allowed